Covered recipient · General Payments record
ALEKSANDR BATIKOV
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$21,727.85
- Reported across 181 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,255.40 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $620.03 | 5 |
| Amgen Inc. | $574.76 | 4 |
| ABBVIE INC. | $273.25 | 2 |
| SCILEX PHARMACEUTICALS INC. | $149.98 | 1 |
| Ardelyx, Inc. | $140.05 | 1 |
| Alkermes, Inc. | $126.11 | 1 |
| GENZYME CORPORATION | $125.00 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $124.97 | 1 |
| Lilly USA, LLC | $121.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.00 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103290187 | CMS |
| ABBVIE INC. | $148.25 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103290189 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $124.97 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146967503 | CMS |
| Alkermes, Inc. | $126.11 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120464291 | CMS |
| Amgen Inc. | $150.00 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111526018 | CMS |
| Amgen Inc. | $124.76 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111526020 | CMS |
| Amgen Inc. | $150.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117199303 | CMS |
| Amgen Inc. | $150.00 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117199305 | CMS |
| Ardelyx, Inc. | $140.05 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146670945 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105470621 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104350796 | CMS |
| AstraZeneca Pharmaceuticals LP | $120.03 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104383049 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104620326 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105298249 | CMS |
| GENZYME CORPORATION | $125.00 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139726532 | CMS |
| Lilly USA, LLC | $121.25 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136011406 | CMS |
| SCILEX PHARMACEUTICALS INC. | $149.98 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136285753 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.